摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-三(苯基)膦亚基乙酰胺 | 38821-11-3

中文名称
2-三(苯基)膦亚基乙酰胺
中文别名
——
英文名称
2-(triphenylphosphoranylidene)acetamide
英文别名
carbamoylmethylene-triphenylphosphorane;Acetamide, 2-(triphenylphosphoranylidene)-;2-(triphenyl-λ5-phosphanylidene)acetamide
2-三(苯基)膦亚基乙酰胺化学式
CAS
38821-11-3
化学式
C20H18NOP
mdl
——
分子量
319.343
InChiKey
NKFMHVSOHCEONZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    43.1
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2931900090

SDS

SDS:937fddcba0d0dbc212c4f768b5a5967b
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    New phosphonium ylides by functionalization of triphenylphosphoranylideneacetamide
    摘要:
    Triphenylphosphoranylideneacetamide undergoes Michael reactions with several acceptors, giving rise, apart from the normal Michael adducts, to the formation of different products like glutarimide ylides and stabilized iminophosphoranes. Wittig reactions with these new ylides lead to a variety of alpha,beta-unsaturated carbonyl compounds.
    DOI:
    10.1016/s0040-4039(00)91662-9
  • 作为产物:
    描述:
    (2-amino-2-oxoethyl)triphenylphosphonium chloridesodium hydroxide 作用下, 以79%的产率得到2-三(苯基)膦亚基乙酰胺
    参考文献:
    名称:
    高度官能化的6-取代的蝶啶的合成。
    摘要:
    描述了由相应的6-醛合成多官能的6-取代的蝶啶的方法。烯烃,酯,酮,酰胺,氰基,肟,溴,甲氧基和二羟基官能团主要都是通过改进的方法学引入的,以使用2-硫代烷基-6-甲酰基蝶啶为底物的Wittig反应。难以对来自Wittig反应的烯烃进行进一步的修饰,但是使用配体辅助的四氧化催化可以将其选择性转化为vic-二醇。这些方法是用于制备可能用作四氢生物蝶呤活性调节剂或用作二氢蝶呤醛缩醛酶抑制剂的化合物的广泛方法的组成部分。
    DOI:
    10.1039/b211564f
  • 作为试剂:
    参考文献:
    名称:
    同源-C-核苷的一般合成
    摘要:
    氢化铝锂还原甲基 (2,3-O-isopropylidene-5-O-trityl-β-D-ribofuranosyl) 乙酸酯得到 2-(2,3-O-isopropylidene-5-O-trityl-β-D-呋喃核糖)乙醇。随后的甲苯磺酰化、氰化物离子置换、腈水解和重氮甲烷甲基化得到 3-(2,3-O-isopropylidene-5-O-trityl-β-D-ribofuranosyl)propionate 丙酸甲酯。碱促进甲酰化,然后用碘甲烷进行甲基化,形成 2-[(2,3-O-isopropylidene-5-O-trityl-β-D-ribofuranosyl)methyl]-3-甲氧基丙烯酸甲酯。甲氧基丙烯酸酯和尿素的碱催化缩合,然后脱保护产生 5-[(β-D-呋喃核糖基)甲基]尿嘧啶。以类似的方式,甲氧基丙烯酸酯与硫脲或胍缩合后,分别得到 5-[(β-D-呋喃核糖基)甲基]-2-硫尿嘧啶和
    DOI:
    10.1246/bcsj.56.2700
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION<br/>[FR] COMPOSÉS MODULANT LE RECRUTEMENT ET/OU LA DÉGRADATION DE PROTÉINES
    申请人:ORIONIS BIOSCIENCES INC
    公开号:WO2021126973A1
    公开(公告)日:2021-06-24
    The invention provides cereblon binders for the degradation of proteins by the ubiquitin proteasome pathway for therapeutic applications.
    这项发明提供了用于通过泛素蛋白酶体途径降解蛋白质的 cereblon 结合物,用于治疗应用。
  • <i>C</i>-Nucleosides and related compounds. XV. The synthesis of <scp>D</scp>,<scp>L</scp>-2′-<i>epi</i>-showdomycin and <scp>D</scp>,<scp>L</scp>-showdomycin
    作者:George Just、T. J. Liak、Mu-Ill Lim、Pierre Potvin、Youla S. Tsantrizos
    DOI:10.1139/v80-322
    日期:1980.10.1

    The conversion of the Diels–Alder adduct of methyl β-nitroacrylate with furan to the title compounds and to D,L-2,5-anhydroglucose derivatives is described.

    将甲基β-硝基丙烯酸酯与呋喃的Diels–Alder加合物转化为标题化合物和D,L-2,5-无葡萄糖生物的过程被描述。
  • The synthesis and evaluation of 6-alkylidene-2'β-substituted penam sulfones as β-lactamase inhibitors
    作者:John D. Buynak、A.Srinivasa Rao、Venkata Ramana Doppalapudi、Greg Adam、Peter J. Petersen、Sirishkumar D. Nidamarthy
    DOI:10.1016/s0960-894x(99)00325-x
    日期:1999.7
    Penicillin sulfones, which structurally incorporate both a 6-position alkylidene substituent and a 2'beta substituent, have been synthesized and evaluated as inhibitors of class C and class A serine beta-lactamases. Incorporation of the 2'beta-substituent generally improves inhibitory activity. Substituents that improve transport across the bacterial cell membrane have also been incorporated.
    已经合成并在结构上结合了6-位亚烷基取代基和2'β取代基的青霉素砜,并被评估为C类和A类丝氨酸β-内酰胺酶的抑制剂。2'β-取代基的掺入通常改善抑制活性。还掺入了改善跨细菌细胞膜运输的取代基。
  • Process for the manufacture of 1-sulpho-2-oxoazetidine carboxylic acid
    申请人:Hoffmann-La Roche Inc.
    公开号:US04652651A1
    公开(公告)日:1987-03-24
    The manufacture of 1-sulpho-2-oxazetidine derivatives of the formula ##STR1## in which Het is an optionally amino-substituted, 5- or 6-membered, aromatic heterocycle containing 1 or 2 nitrogen atoms and optionally also an oxygen or sulphur atom, R.sup.1 is hydrogen, lower alkyl, phenyl-lower alkyl, lower alkanoyl, lower alkoxycarbonyl, lower alkenyl-lower alkyl, lower alkoxycarbonyl-lower alkyl, phenyl-lower-alkoxycarbonyl-lower alkyl, nitrophenyl-lower-alkoxycarbonyl-lower alkyl or carboxy-lower alkyl and R.sup.2 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkoxycarbonyl, lower alkanoyloxy-lower alkyl, lower alkoxycarbonyl-lower alkenyl, hydroxyiminomethyl, lower alkoxyiminomethyl, carbamoyl, carbamoyl-lower alkenyl or carbamoyloxy-lower alkyl, the group .dbd.NOR.sup.1 being present at least partially in the syn-form, in racemic form or in the form of the 3S-enantiomer, and of readily hydrolyzable esters and pharmaceutically compatible salts of these compounds, by acylating a compound of the formula ##STR2## in which R.sup.20 equals R.sup.2 or can also represent a 2,2-dimethyl-1,3-dioxolan-4-yl group and R.sup.3 is hydrogen or sulpho, or a salt thereof with a thioester of the formula ##STR3## in which Het is as above and R.sup.10 has any of the values of R.sup.1 except carboxy-lower alkyl, and can also represent a tri-lower alkyl-silyl-lower-alkoxycarbonyl-lower alkyl group or a carboxy-lower alkyl group converted into a readily hydrolyzable ester group, and the group .dbd.NOR.sup.10 is present at least partially in the syn-form, and carrying out subsequent steps (N-sulphonation, conversion of R.sup.20 into R.sup.2, R.sup.10 into R.sup.1), some of which are optional. The invention also provides certain novel products of formula I and benzthiazolyl thioesters of formula III per se and the preparation of the benzthiazolyl thioesters by esterifying corresponding carboxylic acids. Finally, the invention provides a process for the preparation of carboxylic acids in which R.sup.1 is t-alkoxycarbonylmethyl. The compounds of formula I have antimicrobial activity.
    该专利描述了一种制备1-磺酸-2-噁唑环丙烷生物的方法,其化学式为##STR1##其中Het是一个含有1或2个氮原子和可能还有一个氧原子或原子的可选基取代的5或6元芳香杂环,R.sup.1是氢、低烷基、苯基-低烷基、低烷酰、低烷氧羰基、低烯基-低烷基、低烷氧羰基-低烷基、苯基-低烷氧羰基-低烷基、硝基苯基-低烷氧羰基-低烷基或羧基-低烷基,R.sup.2是氢、低烷基、低烯基、低炔基、低烷氧羰基、低烷酰氧基-低烷基、低烷氧羰基-低烯基、羟基亚胺甲基、低烷氧亚胺甲基、甲酰基、甲酰基-低烯基或甲酰氧基-低烷基,.dbd.NOR.sup.1基团至少部分以syn-形式存在,是外消旋形式或3S-对映体形式,以及这些化合物的易解酯和药用兼容盐的制备方法。
  • 2-Substituted Glutarimides via Preformed Wittig Reagents
    作者:M. J. Wanner、G. J. Koomen
    DOI:10.1055/s-1988-27558
    日期:——
    Triphenylphosphoranylideneacetamide (1) reacts with some Michael-acceptors to give crystalline 2-triphenylphosphoranylidene glutarimides. The Wittig reaction of 2 with several aldehydes in refluxing 1,2-dichloroethane affords the corresponding 2-alkylideneglutarimides 7 in 50-98% yield.
    三苯基膦烯乙酰胺(1)与一些迈克尔受体反应,生成结晶的2-三苯基膦烯戊二酰胺。将2与几种醛在回流的1,2-二氯乙烷中进行维蒂希反应,可得到相应的2-烷基烯戊二酰胺7,产率为50-98%。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫